FT-104
id:
ft-104-219-3040542
title:
FT-104
text:
FT-104 is a psychedelic tryptamine derivative which is a prodrug ester of the well known designer drug 4-HO-DiPT. It is one of a number of related derivatives developed for potential medical applications, and is in human clinical trials as a possible treatment for postpartum depression and treatment-resistant depression. It is being developed by the pharmaceutical company Reunion Neuroscience. As of 2024, FT-104 is entering Phase II clinical trials for post-partum depression.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/FT-104
date created:
2023-04-12T02:06:39Z
date modified:
2024-09-13T13:19:03Z
main entity:
{"identifier":"Q118896392","url":"https://www.wikidata.org/entity/Q118896392"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8d/RE104.svg","width":795,"height":460}
fields total:
13
integrity:
16